Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

Figure 1

Expression of MCT1, MCT2, MCT4 and CD147 in prostate cancer tissue microarrays. Representative images of intensity score 1 (weak) for MCT1 (A), MCT2 (D), MCT4 (G) and CD147 (J), intensity score 2 (moderate) for MCT1 (B), MCT2 (E), MCT4 (H) and CD147 (K) and intensity score 3 (strong) for MCT1 (C), MCT2 (F), MCT4 (I) and CD147 (L) immunostaining for positive cases of prostate carcinoma (score ≥ 4).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us